Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review.

Zhu, Kanghao; Chen, Hui; Xu, Congcong; Chen, Dong; Jin, Zixian; Ren, Sijia; Witharana, Pasan; Chen, Baofu; Shen, Jianfei

Zhu, Kanghao; Chen, Hui; Xu, Congcong; Chen, Dong; Jin, Zixian; Ren, Sijia; Witharana, Pasan; Chen, Baofu; Shen, Jianfei.

Affiliation

Zhu K; Department of Thoracic Surgery, Taizhou Hospital, Zhejiang University, Linhai, China.
Chen H; Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Xu C; Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Chen D; Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Jin Z; Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Ren S; Department of Thoracic Surgery, Taizhou Hospital, Zhejiang University, Linhai, China.
Witharana P; Department of Surgery and Cancer, Imperial College London, London, UK.
Chen B; Department of Thoracic Surgery, Taizhou Hospital, Zhejiang University, Linhai, China.
Shen J; Department of Thoracic Surgery, Taizhou Hospital, Zhejiang University, Linhai, China.

J Thorac Dis ; 15(3): 1186-1195, 2023 Mar 31.

Article in En | MEDLINE | ID: mdl-37065572

Key words

Esophageal squamous cell carcinoma (ESCC); immune checkpoint inhibitors (ICIs); meta-analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: J Thorac Dis Year: 2023 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google